GR-1016
N/A
Report date: 2024/04/23 13:29:36
First In Class
Base Information
Drug NameGR-1016
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGeneQuantum Healthcare (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A